Tag: treatment for haemophilia B
CSL completes acquisition of novel gene therapy for haemophilia B
CSL Limited has wrapped up the acquisition of uniQure’s etranacogene dezaparvovec, a novel gene therapy for the treatment of haemophilia B.
Under the agreement, CSL...
Featured Article
All eyes on Melbourne as Australian Manufacturing Week prepares to open doors
In just four weeks, the spotlight will shine on Australia’s industrial heart as Australian Manufacturing Week 2025 (AMW) takes over Melbourne’s Convention and Exhibition Centre for four days of cutting-edge tech, world-class innovation, and industry-defining conversations.
